Abstract
ABSTRACTHypervirulentKlebsiella pneumoniae(HvKP) is an emerging bacterial pathogen causing invasive infection in immune-competent humans. The hypervirulence is strongly linked to the overproduction of hypermucovisous capsule, but the underlining regulatory mechanism of hypermucoviscosity (HMV) has been elusive, especially at the post-transcriptional level mediated by small noncoding RNAs (sRNAs). Using a recently developed RNA interactome profiling approach, we interrogate the Hfq-associated sRNA regulatory network and establish the intracellular RNA-RNA interactome in HvKP. Our data reveal numerous interactions between sRNAs and HMV-related mRNAs, and identify a plethora of sRNAs that repress or promote HMV. One of the strongest repressors of HMV is ArcZ, which is activated by catabolite regulator CRP and targets many HMV-related genes includingmlaAandfbp. We discover that MlaA and its function in phospholipid transport is crucial for capsule retention and HMV, inactivation of which abolishedKlebsiellavirulence in mice. ArcZ overexpression significantly reduced bacterial burden in mice and reduced HMV in multiple carbapenem-resistant and hypervirulent clinical isolates with diverse genetic background, indicating it is a potent RNA inhibitor of bacterial pneumonia with therapeutic potential. In summary, our work unravels a comprehensive map of the RNA-RNA interaction network of HvKP and identifies a novel CRP-ArcZ-MlaA regulatory circuit of HMV, providing mechanistic insights into the posttranscriptional virulence control in a superbug of global concern.HIGHLIGHTSGlobal RNA-RNA interactome map in hypervirulentKlebsiella pneumoniaeHfq and multiple small RNAs regulate capsular hypermucoviscosityArcZ targetsmlaAthat is required for lipid transport, hypermucoviscosity and virulenceCrp is a transcriptional activator of ArcZ governing a new virulence circuit
Publisher
Cold Spring Harbor Laboratory